The responsiveness of a growth-regulated rat 3Y1 cell line and five clones of 3Y1 cells transformed by the highly oncogenic human adenovirus type 12 to the catecholamine hormone (-)-isoproterenol was studied. The untransformed cells contained f-adrenergic receptors characterized by specific binding of the 1adrenergic receptor antagonist (-)-[3H]dihydroalprenolol, a 9to 12-fold increase in cyclic AMP production in intact cells after incubation with 10 ,uM (-)isoproterenol, and significantly increased adenylate cyclase (ATP pyrophosphatelyase [cyclizing], EC 4.6.1.1) activity in the presence of the hormone. In contrast, (-)-isoproterenol (10 to 100 F.M) had no apparent effect on cyclic AMP production or the basal adenylate cyclase activity in the transformed cell lines. Binding studies revealed that untransformed cells contained approximately 19,400 ,Badrenergic receptor sites per cell. Three transformed cell clones tested showed a threeto fourfold loss of 1-adrenergic receptors.
The 1-adrenergic cell surface receptors involved in catecholamine hormone-mediated physiological events have been demonstrated in a wide variety of cell types (24) . The 1-receptor system is involved functionally in regulating processes as diverse as epithelial chloride transport (48) and central nervous system activity (17) . The ,B-adrenergic effects of catecholamines occur through a receptor-mediated stimulation of the activity of the membrane-associated adenylate cyclase (ATP pyrophosphate-lyase [cycliz- ing], EC 4.6.1.1) which catalyzes cyclic AMP (cAMP) production. Cellular cAMP levels have been implicated in the regulation of cell growth (8, 34) . Exogenous cAMP or its derivatives can inhibit cell division (4, 11-13, 18, 47) . Moreover, it has been suggested that some of the abnormal properties of transformed cells are related to alterations in cAMP metabolism (33) . In keeping with this possibility, transformed cells treated with agents that elevate cAMP levels lose some of the properties of the transformed cell phenotype (15, 16, 31, 39, 43) .
These findings prompted us to examine catecholamine hormone action on adenovirus type 12 (Adl2)-transformed cells. Using growth-regulated rat 3Y1 cells, we have isolated previously clones of 3Y1 cells transformed by the highly oncogenic human Adl2 that have lost the density-dependent growth control (21) . These transformants show other characteristics of the transformed cell phenotype, such as morphological alterations, anchorage-independent growth, and loss of the serum requirement for growth (21) .
We report here the effect of Adl2 transformation on cell response to the synthetic catecholamine (-)-isoproterenol. (-)-Isoproterenol elevated significantly intracellular cAMP levels in 3Y1 cells but not in several independently isolated Adl2-transformed 3Y1 cell lines. (-)-[3H]dihydroalprenolol, a potent 1-adrenergic receptor antagonist, was used to identify and quantitate binding sites, using crude membrane preparations from untransformed and transformed cells. Binding of the ligand demonstrated the stereospecificity expected of binding to adenylate cyclase-coupled 3-adrenergic receptors, as shown by the increased effectiveness of (-)compared to (+)-P-adrenergic stereoisomers in competing for binding sites, rapid and reversible kinetics (steady state by 2 min), high affinity (dissociation constant approximately 25 nM), and saturability, indicating a finite number of hormone receptors. These studies have allowed us to identify quantitative catecholamine hormone receptor differences on 3Y1 and Adl2-transformed 3Y1 cells.
(Some aspects of this research have been presented elsewhere: N. Ledinko Other compounds used were (-)-propranolol and (+)-propranolol from Ayerst Laboratories, New York, N.Y.; (-)-isoproterenol, (+)-isoproterenol, (-)-epinephrine, (-)-norepinephrine, (-)-alprenolol, and (+)-propranolol from Sigma Chemical Co., St. Louis, Mo.; and phentolamine from Ciba-Geigy Corp., Summit, N.J.
Cells and cell growth methodology. A cloned rat 3Y1
cell line, generously provided by G. Kimura, was used previously to construct transformants, using wild-type human Adl2 or the temperature-sensitive mutant, ts401, with an active function required for transformation maintenance (19) (20) (21) . The wild-type transformed clones used were 3Y1/WT-10, 3Y1/WT-12, and 3Y1/ WT-13 (21) . The ts401 mutant-transformed clones tested were 3Y1/401-2 and 3Y1/401-6 (21 (42) kindly supplied by H. Sheppard, Hoffmann-La Roche Inc., Nutley, N.J., with or without (-)-isoproterenol (10 ,uM) or other designated agonists. Antagonists were added together with (-)isoproterenol. The extraction procedure was carried out at 0°C. The cultures were washed once with HBSS scraped into HBSS, and centrifuged at 800 x g for 8 min. Cell extracts were prepared by homogenization of 2 x 107 to 5 x 107 cells in a small volume of a buffered saline solution containing 10 mM NaCl, 10 mM Tris-hydrochloride (pH 7.4), and 4 mM EDTA. A portion of the homogenate was used to determine protein content, and the rest was heated in a boiling water bath for 3 min, and then frozen. After thawing, the samples were centrifuged at 3,000 x g for 10 min to remove particulate material, and the supernatant fraction was taken for cAMP determination. Recovery of cAMP was 60 to 801% as monitored by adding a small amount of [3H]cAMP at the beginning of the extraction procedure.
Adenylate cydase assay. Adenylate cyclase activity was measured essentially by the method of Salomon et al. (37) as modified by Niles et al. (32) . Cells were processed for assay at 0°C. Subconfluent cultures were washed once with HBSS, scraped into HBSS, and centrifuged at 800 x g for 8 min. Cell extracts were prepared by homogenization of 2 x 107 to 5 X 107 cells in a small volume of homogenizing medium containing 150 mM NaCl, 10 mM Tris-hydrochloride, (pH 7.4), and 0.3 mg of phenylmethylsulfonyl fluoride, a protease inhibitor, per ml. We determined that 15 to 20 strokes of a tight-fitting Dounce homogenizer ruptures all or most cells, and maximal enzyme activity is preserved. The incubation mixture contained 25 mM Tris-hydrochloride (pH 7.5), 5 mM MgCl2, 20 mM creatine phosphate, 100 U of creatine phosphokinase per ml, 1 mM cAMP, and 1 mM [a-32P]ATP (50 to 60 cpm/pmol) with or without the designated concentration of (-)-isoproterenol. The reaction was initiated by the addition of 200 to 400 ,ug of the cell protein (this concentration was rate limiting) in a final reaction volume of 100 ,ul. In other experiments, crude membranes prepared as described below were used. The reaction was initiated by the addition of 50 to 80 p.g of membrane protein. After incubation at 30°C for 10 min, the reaction was terminated by adding 100 p.l of "stopping solution" containing 2% sodium dodecyl sulfate, 40 mM ATP, and 1.4 mM cAMP at pH 7.5.
[3H]cAMP (approximately 20,000 cpm) in 50 p.l was added to monitor cAMP recovery. [32P]cAMP was separated from its substrates by using Dowex AG50WX4 columns which were washed with 10 mM Tris-hydrochloride (pH 7.4), after application of the terminated reaction mixture. The cAMP was eluted with 2 ml of water and passed through an alumina column. Samples of the eluate were counted in Aquasol to measure the [32P]cAMP formed. We determined that cAMP recovery was 60 to 80%o, and that formation of cAMP was linear up to 10 to 15 min of incubation and proportional to the protein concentration used. Blanks of 32P contained less than 100 cpm.
Direct binding of (-)-[3HJdihydroalprenolol to crude membrane preparations. The procedure for direct binding of (-)-[3H]dihydroalprenolol to crude membrane preparations has been described (40) . Subconfluent cultures were washed with a buffer of 6 mM Tris-hydrochloride (pH 8.0)-4 mM MgCl2, scraped from the tissue culture flasks, and homogenized (20 strokes). The 5,000 x g pellet, suspended in the above buffer, constituted the crude membrane preparation. The membrane preparations (40 to 130 ,ug of protein) were added to tubes containing (-)-[3H]dihydroalprenolol (final concentration, 1 to 80 nM) and designated competitors with or without 20 ,uM (±)-propranolol in a total volume of 200 ,ul. Tubes were incubated for 13 min at 37°C, and the reaction was terminated by adding 4 ml of the above ice-cold buffer to each tube, followed by filtration through a Whatman GF/C glass fiber filter under low vacuum. The filter was rinsed with a 4-ml wash and a final 8-ml rinse with ice-cold buffer and then dried. The bound tritium was measured by liquid scintillation spectrometry. In each experiment, "nonspecific" binding was determined from parallel assay tubes containing (±)-propranolol, and "specific" binding was the difference between the total and the nonspecific binding. It was determined that 1.7 x 107 untransformed 3Y1 cells and 1.9 x 107 transformed cells each yielded 1 mg of membrane protein.
Protein determination. Protein was determined by the method of Lowry et al. (26) , using crystalline bovine serum albumin as the standard.
RESULTS
Effect of adrenergic activators and inhibitors on cAMP production in untrnsformed cells. The efficacy of (-)-isoproterenol (10 ,uM) to stimulate cAMP production in untransformed cells was greater than that of either (-)-epinephrine (10 ,uM) or (-)-norepinephrine (10 ,M) ( Table  TABLE 1 . Effect of adrenergic agonists and antagonists on intracellular cAMP production in untransformed 3Y1 ceilsa (Table 1) .
(-)-Isoproterenol effect on cAMP content of tansformed cells. A marked difference was found in the response of untransformed and Adl2-transformed 3Y1 cells to (-)-isoproterenol. This agonist (10 ,uM) elevated the intracellular cAMP level approximately ninefold in the untransformed cells, but had no apparent effect on cAMP levels in the five transformants tested ( Table 2 ). In some experiments, up to a 20-fold stimulation was found in untransformed cells.
We have reported previously that intracellular cAMP levels in untransformed 3Y1 cells were generally similar to those in Adl2 transformants (21) . In the present study, the intracellular cAMP content of most of the transformants was about 50%'o of that in untransformed cells ( Table   2 ). These differences appear to be related to cell density, as is shown below.
Cell density and (-)-isoproterenol effect on cAMP content and adenylate cydase. The above experiments were carried out with cultures which were 50 to 70%o confluent. The possibility existed that the transformants might be more responsive to (-)-isoproterenol at lower or higher cell densities. Therefore, the effect of cell density on the (-)-isoproterenol response of the transformed, as well as the untransformed, cells was investigated. In addition, since the intracellular level of cAMP is determined, in part, by the activity of adenylate cyclase, the levels of this enzyme and its response to (-)-isoproterenol were measured in the same experiment.
In the absence of (-)-isoproterenol, the cAMP content and the basal adenylate cyclase in the "light" transformants were similar to that of rapidly growing untransformed 3Y1 cells (Table 3). As the transformants grew to high density, both the cAMP level and the enzyme activity remained essentially unchanged. In contrast, at confluency the contact-inhibited untransformed cells contained an approximately threefold-higher content of cAMP than when rapidly growing; the adenylate cyclase activity increased by a factor of 2 to 3. The nature of the change in enzyme activity which occurs with increasing untransformed cell density remains to be studied. Comparable results were obtained with retrovirus-transformed normal rat kidney cells (1) . In this study, the cyclase activity also increased in the normal fibroblasts with increasing cell density, whereas it remained low in the transformants grown to high cell densities.
The ability of (-)-isoproterenol to increase the cAMP level and adenylate cyclase activity in the untransformed 3Y1 cells was not dependent on cell density (Table 3) . At low or high cell densities, a 9to 12-fold increase in cAMP content and a 3to 4-fold rise in enzyme activity were observed. In sharp contrast, the transformants remained unresponsive to (-)-isoproterenol at low or high cell densities ( Table 3) .
Effect of (-)-isoproterenol exposure time on cAMP content. The cAMP levels in untransformed and Adl2-transformed cells were examined after incubation with (-)-isoproterenol (10 ,uM) for various times (Fig. 1) . A rapid rise in cAMP levels in the transformants was observed throughout the 60-min incubation period. The previous and subsequent experiments were conducted with a 15-min exposure time to (-)isoproterenol. Effect of (-)-isoproterenol concentration on cAMP content. The dependence of cAMP accumulation on (-)-isoproterenol concentrations was examined (Fig. 2 ). Significant elevations of cAMP concentration in untransformed cells were observed first at 0.1 ,uM (-)-isoproterenol, and a maximal response was obtained at a concentration of 10 ,uM. Interference with these responses was observed if the antagonist (-)propranolol (10 ILM) was incubated with (-)isoproterenol. The agonist concentration required to produce a half-maximal response was approximately 0.5 p.M. The transformed cell lines 3YI/WT-10 and 3Y1/401-2, on the other hand, showed no ability to accumulate cAMP even after exposure to 100 F.M (-)-isoproterenol. In addition to these two cell lines, we examined two other transformants, 3Y1/WT-12 and 3Y1/401-6, with similar results.
Binding kinetics of (-)-[3Hldihydroalprenolol.
The ability of (-)-isoproterenol to elevate intracellular cAMP levels is ascribed to its interaction with 3-adrenergic receptors, resulting in a receptor-mediated stimulation of adenylate cyclase activity (25) . The possibility that there were catecholamine hormone receptor differences between untransformed and Ad12-transformed cells was investigated. The ,B-adrenergic hormone receptor sites can be identified directly by using the radiolabeled antagonist, (-)-[3H]di- FIG. 2. (-)-Isoproterenol dose-response curves for intracellular cAMP production in 3Y1, 3Y1/WT-10, and 3Y1/401-2 cells. The cAMP assay is described in the text. Each assay was done in triplicate, with no difference greater than ±15% of the mean in two separate experiments. 3Y1 cultures were incubated with (-)-isoproterenol alone or (-)-isoproterenol plus (-)-propranolol (10 pLM). hydroalprenolol (22) . Specific binding of (-)-[3H]dihydroalprenolol to crude membrane preparations of 3Y1 and 3Y1/WT-10 cells was rapid, reaching a steady state in approximately 2 min (Fig. 3 ). The binding was completely reversible by (+)-propranolol (10 ,uM) (Table 4 ). In contrast, when Scatchard plots were performed on three Adl2-transformed clones, an approximately threeto fourfold loss of ,B-adrenergic receptors of these clones was seen. With the possible exception of 3Y1/WT-10 cells, this loss of receptors did not appear to be accompanied by a significant change in the affinity of the remaining receptors for (-)-[3H]dihydroalprenolol. Specifidty of (-)-_3Hldihydroalprenolol binding. The (-)-[3H]dihydroalprenolol binding sites exhibited stereospecificity in binding the P-adrenergic antagonist, propranolol, or the agonist, isoproterenol (Fig. 5 ). In each case the (-)isomer bound with considerably greater affinity than did the corresponding (+)-isomer. The (-)isomers were approximately three orders of magnitude more potent in competing for the a The number of (-)-[3H]dihydroalprenolol binding sites per cell and binding affinities were calculated from Scatchard binding plots obtained as described for 3Y1 and 3Y1/WT-10 in the legend to Fig. 4 . Slope for the plot gives the apparent affinity constant, and the intercept on the abscissa gives the binding capacity in terms of femtomoles bound per milligam of membrane protein. About 1.7 x 10' untransformed 3Y1 cells and 1.9 x 107 transformed cells each yielded 1 mg of membrane protein.
hormone receptor sites. Additionally, the aadrenergic antagonist, phentolamine, showed no affinity for the binding sites at a concentration of 150 ,uM. The concentration of (-)-isoproterenol causing half-maximal inhibition of (-)-[3H]dihydroalprenolol binding was 0.7 ,uM ( Fig. 5 ). This concentration provides an estimate of the apparent dissociation constant of (-)-isoproterenol for the receptor and is inversely related to its affinity. A comparison was made of the (-)isoproterenol binding affinity and the concentration causing half-maximal activation of adenylate cyclase with crude cell membrane preparations. The enzyme activity of 3Y1 or 3Y1/WT-10 cell membrane preparations was measured in the presence of increasing concentrations of (-)-isoproterenol ( Fig. 6 ). Half-maximal activation of 3Y1 membrane adenylate cyclase occurred at a (-)-isoproterenol concentration of 0.5 ,uM, indicating that the potency of (-)-isoproterenol for activation of adenylate cyclase and for inhibition of binding was similar. In keeping with previous results, no activation of the enzyme by (-)-isoproterenol was found with the transformed cell membrane preparation. The purine nucleotide GTP has been shown in some catecholamine-sensitive systems to activate a hormone response of adenylate cyclase (5, 23, 36) . Incorporation of 50 ,uM GTP in the reaction mixture in addition to the agonist, however, did not enhance enzyme activity. 
DISCUSSION
The present findings suggest an association between Adl2 transformation and loss of ,Badrenergic hormone binding sites, although the biological significance of these receptors in cultured cells is unknown. In a previous study, transformation of 3T3 cells with simian virus 40 resulted in a decrease in the number of (-)norepinephrine receptors (40) . These results parallel observations which indicate that leukemic lymphocytes have fewer than 30%o of the 3adrenergic sites of normal lymphocytes (41) . Additionally, transformation of rat cells with AdS or chemical carcinogens brings about a marked loss in the binding of epidermal growth factor to surface receptors (10), as was shown previously with sarcoma virus-transformed cells (9) and more recently with Abelson murine leukemia virus (3) . A loss of epidermal growth factor binding sites has been found also with our Adl2 transformants (P. Fisher, personal communication). Furthermore, 3Y1 cells transformed by chemical carcinogens show a significant reduction in the number of 3-adrenergic hormone receptors (unpublished data). These findings suggest that cell transformation is associated with specific changes in hormone and growth factor receptor systems.
In our study using untransformed 3Y1 cells, Effect of different concentrations of (-)isoproterenol on adenylate cyclase activity in crude membrane preparations from 3Y1 and 3Y1/WT-10 cells. The enzyme assay is described in the text. The basal enzyme activity (picomoles of cAMP per minute per milligram of membrane protein) was 3.8 for 3Y1 and 3.0 for 3Y1I/WT-10 cells. Values shown are the means of duplicate determinations, with no difference greater than ±20o of the mean.
(-)-isoproterenol increased significantly adenylate cyclase activity and intracellular cAMP levels, whereas the hormone had no apparent effect on these parameters in Adl2-transformed cell lines. This finding is in keeping with other studies where a predominant difference between untransformed and transformed cells has been a decreased responsiveness of adenylate cyclase to various hormones (34) . For example, (-)norepinephrine significantly elevates cAMP levels in 3T3 cells, whereas simian virus 40-transformed 3T3 cells show a lesser response (40) . Then there is a loss of adenylate cyclase sensitivity to a variety of catecholamines, as well as prostaglandins, in chemically transformed epithelial cells (28) . A decreased adenylate cyclase response to hormones has been found in in vivo studies as well. Recently, a decreased (-)-isoproterenol responsiveness has been found in mouse epidermal papillomas during tumor promotion with phorbol myristate acetate (14) . The biochemical basis for the loss of sensitivity to various hormones in in vitro-transformed and in tumor cells is unknown.
It seems reasonable to assume that the loss of (-)-isoproterenol-stimulated adenylate cyclase activity in Adl2-transformed cells is related to the loss of 3-adrenergic receptors. In keeping with this possibility, S49 lymphoma cell mutants selected for decreased catecholamine hormone response also had corresponding losses in 1-adrenergic receptors (27) . Other cell systems have shown decreases in their maximal isoproterenol responses when 3-adrenergic receptors were blocked. After prolonged incubation of human astrocytoma cells with (-)-isoproterenol, the degree of loss of adenylate cyclase response to the hormone and of P-adrenergic binding sites was similar (44) . By contrast, catecholamines could elicit full biological responses in glioma cells and isolated atria even though the great majority of 3-adrenergic receptors were blocked persistently (45) . It was hypothesized that full activation is possible despite receptor loss if each hormone-activated receptor molecule has access to many, if not all, adenylate cyclase molecules. After completion of the initial receptor-cyclase interaction, the receptor(s) is free to activate additional enzyme molecules (46) . If so, this hypothesis predicts that receptor molecules in transformed cells cannot be hormonally activated or do not have access to functioning adenylate cyclase molecules or both.
Recent pertinent results have shown that the propranolol-receptor complex is cytoskeletally linked (7) . In this study, the P-adrenergic receptors were linked to the microtubules of the cellular cytoskeleton in the frog erythrocyte. It was proposed that the function of the cytoskeleton is to maintain a fixed spatial relationship between the receptor and its effector. Then, agonists could cause the receptor to become unbound from the cytoskeleton in the form of an agonist-receptor complex, thereby activating adenylate cyclase.
Microtubules are found in association with microfilaments and with cell membranes, and these cytoskeletal elements are involved in controlling the distribution and mobility of certain cell receptors (30) . Viral transformation of cells is associated with a disruption of microfilament organization (2, 29, 35) . The resulting changes in the membrane-associated cytoskeletal systems in Adl2-transformed cells could result in an alteration of the cellular control of the mobility and topography of the 3-adrenergic, and possibly epidermal growth factor receptors, leading to a loss or masking of these receptors or both. Whether the loss of ,3-adrenergic receptors is indirectly attributable to expression of the transformed phenotype or is directly related to an altered cAMP metabolism or both remains to be investigated. Adl2 transformation thus provides an excellent model system for investigating molecular events in malignant transformation. 
